TITLE

Effect of GnRH Agonists on Implantation

PUB. DATE
December 2006
SOURCE
Fertility Weekly;12/18/2006, p2
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article cites a study conducted by researchers from Spain which found that the use of gonadotropin-releasing hormone (GnRH) agonist for ovulation does not affect the rate of embryo implant. The study has evaluated the capacity of embryos derived from oocytes matured with bolus of GnRH agonist to implant. Researchers have demonstrated that the embryo is not altered by the agonist and suggested that the decrease in pregnancy rates is associated with luteolysis.
ACCESSION #
23637482

 

Related Articles

  • Low dose gonadotropin-releasing hormone agonist treatments with early discontinuation for controlled ovarian hyperstimulation in an in vitro fertilization program. Lee, Su-Long; Su, Jinu-Hwang; Ikuta, Katsuo; Suzumori, Kaoru // Reproductive Medicine & Biology;Mar2003, Vol. 2 Issue 1, p25 

    Aim: The purpose of the present study was to investigate the applicability of a protocol for controlled ovarian hyperstimulation (COH) featuring early discontinuation of low dose gonadotropin-releasing hormone agonist (GnRHa) for ovulation induction for in vitro fertilization (IVF). Methods:...

  • Comparison of GnRHa Flare Protocol and Long GnRHa Suppression. Confino, E. // Fertility Weekly;4/26/2004, p5 

    Compares the outcome of in vitro fertilization after using gonadotropin-releasing-hormone-agonist (GnRHa) flare protocol with the after long suppression GnRHa in poor responders. Efficacy of administering GnRH agonist early in the menstrual cycle; Details on the biological significance reflected...

  • Award Winners:.  // Iranian Journal of Reproductive Medicine;Spring2011 Supplement, Vol. 9, p19 

    The article presents abstracts on topics related to reproductive medicine which include the effect of frozen and fresh embryo transfer in early pregnancy and neonatal outcomes, the in vitro fertilization (IVF) outcome of mild and microdose luteinizing hormone releasing hormone (GnRH) agonist...

  • ART/Ovarian stimulation 1.  // Human Reproduction;Jun2003 Supplement 1, Vol. 18, p28.1 

    The article presents abstracts of research related to ovarian stimulation. They include "A prospective, randomized trial of three ovulation induction protocols of IVF including a novel approach with low-dose HCG and GnRH antagonist in the mid-late follicular phase," "Timing of HCG administration...

  • Effects and Optimal Timing of HCG Supplementation of GnRHa.  // Fertility Weekly;12/18/2006, p4 

    The article cites a study conducted by researchers from Denmark which determined the effects of human chorionic gonadotropin (HCG) supplementation and optimal timing of HCG administration in vitro fertilization/intracytoplasmic sperm injection patients. The researchers have revealed that...

  • Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist cetrorelix. Asimakopoulos, Byron; Nikolettos, Nikos; Al-Hasani, Safaa // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p52 

    The present retrospective study evaluated the outcome of frozen-thaw cycles with oocytes obtained either during a multiple dose protocol of cetrorelix, or after the use of a gonadotrophin-releasing hormone (GnRH) agonist. A total of 101 subfertile couples were included. These couples had a total...

  • Duration of Stimulation is Shorter with GnRH Antagonist for Poor Responders.  // Fertility Weekly;2/20/2012, p8 

    The article reports on the study conducted by D. Pu and colleagues which evaluates the efficacy of luteinizing hormone releasing hormone antagonist (GnRH-ant) versus GnRh agonist (GnRH-a) protocols for ovarian stimulation in poor responders of in vitro fertilization (IVF). The researchers...

  • Clomiphene citrate versus gonadotrophins for ovulation stimulation. Dorn, Christoph; Van der Ven, Hans // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jun2005 Supplement 3, Vol. 10, p37 

    Clomiphene (clomiphene citrate) remains the drug of first choice in women suffering from anovulation and in ovulating women with inadequate follicular or luteal development. In ovarian stimulation for various assisted reproductive techniques, the role of clomiphene remains limited, because the...

  • Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study. Isik, A. Z.; Caglar, G. S.; Sozen, E.; Akarsu, C.; Tuncay, G.; Ozbicer, T.; Vicdan, K. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Oct2009, Vol. 19 Issue 4, p472 

    This study was designed to evaluate the effect of luteal-phase administration of single-dose gonadotrophin-releasing hormone (GnRH) agonist on pregnancy, implantation and live birth rates in patients who received GnRH antagonist for pituitary suppression. The study population consisted of 164...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics